Home › Cancer (all types) › NCT01885299
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Multi-Institution Registry of SRS/SBRT Procedures
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy * Willingness to sign an Informed Consent Document or verbally agree to participation Exclusion Criteria: * There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included
About the study
The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)
What is being tested
- SRS/SBRT (radiation)
Sponsor: The Radiosurgery Society · Participants: 50,000 · Started: 2012-03
Contact the study team
Official record on ClinicalTrials.gov — NCT01885299
Locations in the U.S.
| Florida | Sylvester Comprehensive Cancer Center, University of Miami, Miami |
| Michigan | Henry Ford Health System, Detroit |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.